Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Parkinsonism: onset, progression, and mortality

Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · see citing works

THE UNLABELED ANTIBODY ENZYME METHOD OF IMMUNOHISTOCHEMISTRY PREPARATION AND PROPERTIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEX (HORSERADISH PEROXIDASE-ANTIHORSERADISH PEROXIDASE) AND ITS USE IN IDENTIFICATION OF SPIROCHETES

Sternberger, L. A., Hardy, P. H., Cuculis, J. J., & Meyer, H. G. (1970) · Journal of Histochemistry & Cytochemistry · doi:10.1177/18.5.315 · Cited by 5,042 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

Diagnosis of Alzheimer's Disease

Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499 · see citing works

MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE

Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757 · see citing works

The effect of age on the non-haemin iron in the human brain

Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427 · see citing works

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397 · see citing works

Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains

Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383 · see citing works

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,377 · see citing works

FERRITIN: STRUCTURE, GENE REGULATION, AND CELLULAR FUNCTION IN ANIMALS, PLANTS, AND MICROORGANISMS

Theil, E. C. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.001445 · Cited by 1,337 · see citing works

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · see citing works

Increased nigral iron content in postmortem parkinsonian brain

Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963 · see citing works

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

Langston, J. W., Forno, L. S., Rebert, C. S., & Irwin, I. (1984) · Brain Research · doi:10.1016/0006-8993(84)90777-7 · Cited by 922 · see citing works

The Prevention of Acute Gastric Ulcer in the Rat by α-Methyldopa

DJAHANGUIRI, B., Hemmati, S., Sadeghi, D., & Firouzabadi, A. (2008) · Medicina et Pharmacologia Experimentalis · doi:10.1159/000137111 · Cited by 783 · see citing works

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

Sofic, E., Riederer, P. F., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G. F., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 754 · see citing works

Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease

Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., SATO, T. A., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 735 · see citing works

Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation

Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709 · see citing works

The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases

Tierney, M. C., Fisher, R. H., Lewis, A. J., Zorzitto, M. L., Snow, W. G., Reid, D. W., & Nieuwstraten, P. (1988) · Neurology · doi:10.1212/wnl.38.3.359 · Cited by 613 · see citing works

Identification of the iron-responsive element for the translational regulation of human ferritin mRNA

Hentze, M. W., Caughman, S. W., Rouault, T. A., Barriocanal, J. G., Dancis, A., Harford, J. B., & Klausner, R. D. (1987) · Science · doi:10.1126/science.3685996 · Cited by 571 · see citing works

Rate of cell death in parkinsonism indicates active neuropathological process

McGeer, P. L., Itagaki, S., Akiyama, H., & McGeer, E. G. (1988) · Annals of Neurology · doi:10.1002/ana.410240415 · Cited by 557 · see citing works

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

Sofic, E., Paulus, W., Jellinger, K. A., Riederer, P. F., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02017.x · Cited by 523 · see citing works

Brain Peroxidase and Catalase in Parkinson Disease

Ambani, L. M., Woert, M. H. V., & Murphy, S. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490440064010 · Cited by 404 · see citing works

Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases.

Iacopino, A. M., & Christakos, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4078 · Cited by 388 · see citing works

Parkinson's disease and movement disorders

Filho, R. M. (1989) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x1989000400025 · Cited by 359 · see citing works

Glutathione peroxidase activity in Parkinson's disease brain

Kish, S. J., Morito, C. L. H., & Hornykiewicz, O. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90078-3 · Cited by 301 · see citing works

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb01782.x · Cited by 292 · see citing works

Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

Drayer, B. P., Olanow, W. C., Burger, P. C., Johnson, G. A., Herfkens, R. J., & Riederer, S. J. (1986) · Radiology · doi:10.1148/radiology.159.2.3961182 · Cited by 259 · see citing works

Decreased ferritin levels in brain in Parkinson's disease

Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258 · see citing works

Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia

Grundke, I., Fleming, J. T., Tung, Y. C., Lassmann, H., Iqbal, K., & Joshi, J. G. (1990) · Acta Neuropathologica · doi:10.1007/bf00334497 · Cited by 253 · see citing works

Iron and free radical reactions: two aspects of antioxidant protection

Halliwell, B. B., & Gutteridge, J. M. C. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90207-0 · Cited by 250 · see citing works

Clinicopathological analysis of dementia disorders in the elderly

Jellinger, K. A., Danielczyk, W., Fischer, P. A., & Gabriel, E. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90072-u · Cited by 243 · see citing works

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

Earle, K. M. (1968) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196801000-00001 · Cited by 227 · see citing works

Post-mortem distribution of dopamine and homo-vanillic acid in human brain, variations related to age, and a review of the literature

Adolfsson, R., Gottfries, C. G., Roos, B. E., & Winblad, B. G. (1979) · Journal of Neural Transmission · doi:10.1007/bf01250085 · Cited by 218 · see citing works

Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels.

White, K., & Munro, H. N. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68398-x · Cited by 208 · see citing works

Magnetic Resonance Imaging of Brain Iron

Drayer, B. P., Burger, P. C., Darwin, R. H., Riederer, S. J., Herfkens, R. J., & Johnson, G. A. (1986) · Europe PMC (PubMed Central) · Cited by 176 · see citing works

Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family

Rozemüller, A. J. M., Eikelenboom, P., Pals, S. T., & Stam, F. C. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90547-8 · Cited by 173 · see citing works

MPTP: A neurotoxin producing a parkinsonian syndrome

Crossman, A. R. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90228-4 · Cited by 169 · see citing works

Ferritin immunohistochemistry as a marker for microglia

Kaneko, Y., Kitamoto, T., Tateishi, J., & Yamaguchi, K. (1989) · Acta Neuropathologica · doi:10.1007/bf00294369 · Cited by 153 · see citing works

Ferritin: isolation of aluminum-ferritin complex from brain.

Fleming, J. T., & Joshi, J. G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.7866 · Cited by 149 · see citing works

The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and Man

Burns, R. S., Markey, S. P., Phillips, J. M., & Chiueh, C. C. (1984) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100046345 · Cited by 142 · see citing works

Iron uptake and utilization by mammalian cells. I: Cellular uptake of transferrin and iron

Octave, J., Schneider, Y., Trouet, A., & Crichton, R. R. (1983) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(83)90217-7 · Cited by 136 · see citing works

Microtechnical Demonstration of Iron: A Criticism of its Methods.

Gömöri, G. (1936) · PubMed · Cited by 130 · see citing works

Pathology of Parkinson's disease

Forno, L. S. (1981) · Movement Disorders · doi:10.1016/b978-0-407-02295-9.50008-4 · Cited by 123 · see citing works

Long‐term consequence of early iron‐deficiency on dopaminergic neurotransmission in rats

Ben‐Shachar, D., Ashkenazi, R., & Youdim, M. B. H. (1986) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(86)90019-5 · Cited by 115 · see citing works

Effect of ferritin-containing fractions with different iron loading on lipid peroxidation

Gutteridge, J. M. C., Halliwell, B. B., Treffry, A., Harrison, P. M., & Blake, D. R. (1983) · Biochemical Journal · doi:10.1042/bj2090557 · Cited by 113 · see citing works

T2 values in the human brain: comparison with quantitative assays of iron and ferritin.

Chen, J. C., Hardy, P., Clauberg, M., Joshi, J. G., Parravano, J. G., Deck, J. H. N., Henkelman, R. M., Becker, L. E., & Kucharczyk, W. (1989) · Radiology · doi:10.1148/radiology.173.2.2798884 · Cited by 108 · see citing works

An autoradiographic study of the uptake and distribution of iron by the brain of the young rat

Dwork, A. J., Lawler, G., ZYBERT, P. A., Durkin, M. M., Osman, M., Willson, N. J., & Barkai, A. I. (1990) · Brain Research · doi:10.1016/0006-8993(90)90950-g · Cited by 99 · see citing works

Do oligodendrocytes mediate iron regulation in the human brain?

Gerber, M. R., & Connor, J. R. (1989) · Annals of Neurology · doi:10.1002/ana.410260115 · Cited by 87 · see citing works

Apolipoprotein A-IV Polymorphism in the Finnish Population: Gene Frequencies and Description of a Rare Allele

Lukka, M., Metso, J., & Ehnholm, C. (1988) · Human Heredity · doi:10.1159/000153814 · Cited by 74 · see citing works

The role of iron in the basal ganglion.

Youdim, M. B. H., Ben‐Shachar, D., Yehuda, S., & Riederer, P. F. (1990) · PubMed · Cited by 55 · see citing works

Iron-induced lipid peroxidation and inhibition of dopamine synthesis in striatum synaptosomes

Zaleska, M. M., Nagy, K., & Floyd, R. A. (1989) · Neurochemical Research · doi:10.1007/bf00964867 · Cited by 51 · see citing works

Jaw and blink reflexes in trigeminal nerve lesions

Goor, C., & de Visser, B. W. O. (1976) · Neurology · doi:10.1212/wnl.26.1.95 · Cited by 39 · see citing works

Ferritin: an iron storage protein with diverse functions.

Joshi, J. G., & Clauberg, M. (1988) · PubMed · Cited by 30 · see citing works

Memory deficits in advanced Parkinson's disease

Fischer, P. A., Gatterer, G., Simányi, M., Jellinger, K. A., Marterer, A., Danielczyk, K., & Danielczyk, W. (1990) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251246 · Cited by 21 · see citing works

Oxidative stress in Parkinson's disease

Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · see citing works

Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging

Que, E. L., Domaille, D. W., & Chang, C. J. (2008) · Chemical Reviews · doi:10.1021/cr078203u · Cited by 2,063 · see citing works

The role of iron in brain ageing and neurodegenerative disorders

Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819 · see citing works

Iron, brain ageing and neurodegenerative disorders

Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801 · see citing works

Role of GPX4 in ferroptosis and its pharmacological implication

Seibt, T. M., Proneth, B., & Conrad, M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.014 · Cited by 1,520 · see citing works

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659 · see citing works

Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo

Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620 · see citing works

Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review

Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 567 · see citing works

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554 · see citing works

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease

Jenner, P. G., Dexter, D. T., Sian, J., Schapira, A. H. V., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320714 · Cited by 545 · see citing works

Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain

Liu, C., Li, W., Tong, K. A., Yeom, K. W., & Kuzminski, S. J. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24768 · Cited by 508 · see citing works

Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases

Weinreb, O., Mandel, S. A., Amit, T., & Youdim, M. B. H. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.05.002 · Cited by 506 · see citing works

Oxidative stress: Free radical production in neural degeneration

Götz, M. E., Künig, G., Riederer, P. F., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 479 · see citing works

Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation

Huat, T. J., Camats‐Perna, J., Newcombe, E. A., Valmas, N., Kitazawa, M., & Medeiros, R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.018 · Cited by 483 · see citing works

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

Good, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427 · see citing works

Iron, Neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

Zecca, L., Gallorini, M., Schünemann, V., Trautwein, A. X., Gerlach, M., Riederer, P., Vezzoni, P., & Tampellini, D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00186.x · Cited by 401 · see citing works

Glutathione, iron and Parkinson’s disease

Bharath, S., Hsu, M., Kaur, D., Rajagopalan, S., & Andersen, J. K. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01174-7 · Cited by 394 · see citing works

Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease

Mosley, R. L., Benner, E. J., Kadiu, I., Thomas, M., Boska, M. D., Hasan, K. M., Laurie, C. D., & Gendelman, H. E. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.006 · Cited by 388 · see citing works

Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders

Youdim, M. B. H., & Buccafusco, J. J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.11.007 · Cited by 382 · see citing works

An introduction to the free radical hypothesis in Parkinson's disease

Olanow, C. W. (1992) · Annals of Neurology · doi:10.1002/ana.410320703 · Cited by 382 · see citing works

Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases

Mandel, S. A., Weinreb, O., Amit, T., & Youdim, M. B. H. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02291.x · Cited by 379 · see citing works

Brain iron pathways and their relevance to Parkinson's disease

Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., & Becker, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00608.x · Cited by 362 · see citing works

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples

Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361 · see citing works

The relevance of iron in the pathogenesis of Parkinson’s disease

Sian‐Hülsmann, J., Mandel, S. A., Youdim, M. B. H., & Riederer, P. F. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07132.x · Cited by 349 · see citing works

Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease

Fedorow, H., Tribl, F., Halliday, G. M., Gerlach, M., Riederer, P. F., & Double, K. L. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.001 · Cited by 347 · see citing works

The Relevance of Iron in the Pathogenesis of Parkinson's Disease

Götz, M. E., Double, K. L., Gerlach, M., Youdim, M. B. H., & RIEDERERE, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.017 · Cited by 342 · see citing works

Oxidative stress in Alzheimer's disease

Chauhan, V. P. S., & Chauhan, A. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.004 · Cited by 341 · see citing works

T1 and T2 in the Brain of Healthy Subjects, Patients with Parkinson Disease, and Patients with Multiple System Atrophy: Relation to Iron Content

Vymazal, J., Righini, A., Brooks, R. A., Canesi, M., Mariani, C. B., Leonardi, M., & Pezzoli, G. (1999) · Radiology · doi:10.1148/radiology.211.2.r99ma53489 · Cited by 341 · see citing works

High‐field magnetic resonance imaging of brain iron: birth of a biomarker?

Schenck, J. F., & Zimmerman, E. A. (2004) · NMR in Biomedicine · doi:10.1002/nbm.922 · Cited by 330 · see citing works

Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE

Ayton, S., Faux, N. G., Bush, A. I., Initiative, A. D. N., Weiner, M. W., Aisen, P. S. S., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2015) · Nature Communications · doi:10.1038/ncomms7760 · Cited by 330 · see citing works

PI3K is a key molecule in the Nrf2‐mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells

Nakaso, K., Yano, H., Fukuhara, Y., Takeshima, T., Wada‐Isoe, K., & Nakashima, K. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00517-9 · Cited by 324 · see citing works

Microglial pathology

Streit, W. J., Xue, Q.-S., Tischer, J., & Bechmann, I. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0142-6 · Cited by 317 · see citing works

Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis

Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313 · see citing works

The possible role of iron in the etiopathology of parkinson's disease

Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1993) · Movement Disorders · doi:10.1002/mds.870080102 · Cited by 301 · see citing works

Neural Heme Oxygenase-1 Expression in Idiopathic Parkinson's Disease

Schipper, H. M., Liberman, A., & Stopa, E. G. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6752 · Cited by 300 · see citing works

Iron in Neurodegeneration – Cause or Consequence?

Ndayisaba, A., Kaindlstorfer, C., & Wenning, G. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00180 · Cited by 298 · see citing works

Unity in the Biochemistry of the Iron-Storage Proteins Ferritin and Bacterioferritin

Honarmand Ebrahimi, K., Hagedoorn, P.-L., & Hagen, W. R. (2015) · Chemical Reviews · doi:10.1021/cr5004908 · Cited by 297 · see citing works

Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-κB) activation and cell death by tea extracts in neuronal cultures11Abbreviations: BT, Black Tea; EMSA, Electromobility Shift Assay; EGCG, (-)-Epigallocatechin-3-gallate; GT, Green Tea; NB SH-SY5Y cells, Human neuroblastoma SH-SY5Y cells; 6-OHDA, 6-hydroxydopamine; IL, Interleukin; LDH, Lactate Dehydrogenase; MPTP, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NF-κB, nuclear factor-κB; OS, Oxidative Stress; PD, Parkinson’s Disease; ROS, Reactive Oxygen Species; SNPC, Substantia Nigra Pars Compacta; TBARS, thiobarbituric acid reactive substances.

Levites, Y., Youdim, M. B. H., Maor, G., & Mandel, S. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00813-9 · Cited by 291 · see citing works

Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging

Callaghan, M. F., Freund, P., Draganski, B., Anderson, E., Cappelletti, M., Chowdhury, R., Diedrichsen, J., FitzGerald, T. H. B., Smittenaar, P., Helms, G., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.008 · Cited by 292 · see citing works

Green tea catechins as brain‐permeable, natural iron chelators‐antioxidants for the treatment of neurodegenerative disorders

Mandel, S. A., Amit, T., Reznichenko, L., Weinreb, O., & Youdim, M. B. H. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500156 · Cited by 293 · see citing works

Iron and dopamine: a toxic couple

Hare, D. J., & Double, K. L. (2016) · Brain · doi:10.1093/brain/aww022 · Cited by 284 · see citing works

Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease

Simmons, D. A., Casale, M., Alcon, B., Pham, N., Narayan, N., & LYNCH, G. S. (2007) · Glia · doi:10.1002/glia.20526 · Cited by 277 · see citing works

Oxytosis/Ferroptosis—(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System

Lewerenz, J., Ates, G., Methner, A., Conrad, M., & Maher, P. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00214 · Cited by 273 · see citing works

Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion

Schrag, M., Mueller, C., Oyoyo, U. E., Smith, M. A., & Kirsch, W. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.001 · Cited by 266 · see citing works

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

Shachar, D. B., Kahana, N., Kampel, V., Warshawsky, A., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.005 · Cited by 246 · see citing works

Gene expression analysis in N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R‐apomorphine

Grünblatt, E., Mandel, S. A., Maor, G., & Youdim, M. B. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00397.x · Cited by 246 · see citing works

Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties

Weinreb, O., Amit, T., Mandel, S. A., & Youdim, M. B. H. (2009) · Genes & Nutrition · doi:10.1007/s12263-009-0143-4 · Cited by 244 · see citing works

Neuroprotective Strategies in Parkinson???s Disease

Mandel, S. A., Grünblatt, E., Riederer, P. F., Gerlach, M., Levites, Y., & Youdim, M. B. H. (2003) · CNS Drugs · doi:10.2165/00023210-200317100-00004 · Cited by 238 · see citing works

Brain iron metabolism: Neurobiology and neurochemistry

Ke, Y., & Qian, Z. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.009 · Cited by 236 · see citing works

Heme oxygenase expression in human central nervous system disorders

Schipper, H. M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.015 · Cited by 237 · see citing works

In Vivo Evaluation of Brain Iron in Alzheimer Disease Using Magnetic Resonance Imaging

Bartzokis, G., Sultzer, D. L., Cummings, J. L., Holt, L. E., Hance, D. B., Henderson, V. W., & Mintz, J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.47 · Cited by 235 · see citing works

Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6‐Hydroxydopamine and Iron Chelators, Desferal and VK‐28

YOUDIM, M. B. H., STEPHENSON, G., & SHACHAR, D. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.025 · Cited by 233 · see citing works

Chemistry and biology of ferritin

Plays, M., Müller, S., & Rodriguez, R. (2021) · Metallomics · doi:10.1093/mtomcs/mfab021 · Cited by 232 · see citing works

Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease

Faucheux, B. A., Martin, M., Beaumont, C., Hauw, J., Agid, Y., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01923.x · Cited by 229 · see citing works

Expression of αB-crystallin in Alzheimer's disease

Renkawek, K., Voorter, C., Bosman, G. C. G. M., van Workum, F. V., & de Jong, W. D. (1994) · Acta Neuropathologica · doi:10.1007/bf00296185 · Cited by 157 · see citing works

The Role of Iron in Neurodegeneration: Prospects for Pharmacotherapy of Parkinson??s Disease

Jellinger, K. A. (1999) · Drugs & Aging · doi:10.2165/00002512-199914020-00004 · Cited by 218 · see citing works

The mechanism of ferroptosis and its related diseases

Feng, S., Tang, D., Wang, Y., Li, X., Bao, H., Tang, C., Dong, X., Li, X., Yang, Q., Yan, Y., et al. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00142-2 · Cited by 224 · see citing works

Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.

Faucheux, B. A., Nillesse, N., Damier, P., Spik, G., Prigent, A., Pierce, A., Leveugle, B., Kubis, N., Hauw, J., & Agid, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9603 · Cited by 218 · see citing works

Region‐specific disturbed iron distribution in early idiopathic P arkinson's disease measured by quantitative susceptibility mapping

He, N., Ling, H., Ding, B., Huang, J., Zhang, Y., Zhang, Z., Liu, C., Chen, K., & Yan, F. (2015) · Human Brain Mapping · doi:10.1002/hbm.22928 · Cited by 216 · see citing works

In vivo detection of iron and Neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage

Zecca, L., Berg, D., Arzberger, T., Ruprecht, P., Rausch, W. D., Musicco, M., Tampellini, D., Riederer, P., Gerlach, M., & Becker, G. (2005) · Movement Disorders · doi:10.1002/mds.20550 · Cited by 214 · see citing works

MRI evaluation of brain iron in earlier- and later-onset Parkinson’s disease and normal subjects

Bartzokis, G., Cummings, J. L., Markham, C. H., Marmarelis, P. Z., Treciokas, L. J., Tishler, T. A., Marder, S. R., & Mintz, J. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00155-6 · Cited by 212 · see citing works

Meta-analysis of brain iron levels of Parkinson’s disease patients determined by postmortem and MRI measurements

Wang, J., Zhuang, Q.-Q., Zhu, L.-B., Zhu, H., Li, T., Li, R., Chen, S., Huang, C.-P., Zhang, X., & Zhu, J. (2016) · Scientific Reports · doi:10.1038/srep36669 · Cited by 209 · see citing works

Mitochondrial dysfunction, oxidative stress and neurodegeneration

Mancuso, M., Coppedè, F., Migliore, L., Siciliano, G., & Murri, L. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10110 · Cited by 209 · see citing works

Oxidative stress as a cause of Parkinson's disease

Jenner, P. G., & Jenner, P. G. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb05013.x · Cited by 205 · see citing works

Emerging roles of pathogens in Alzheimer disease

Miklossy, J. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002006 · Cited by 199 · see citing works

Dopamine- and l-β-3,4-dihydroxyphenylalanine hydrochloriDe (l-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y Cells

Lai, C., & Yu, P. H. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00731-9 · Cited by 198 · see citing works

Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats

Ben‐Shachar, D., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06432.x · Cited by 197 · see citing works

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease

Mastroberardino, P. G., Hoffman, E. K., Horowitz, M. P., Betarbet, R., Taylor, G., Cheng, D., Na, H. M., Gutekunst, C.-A., Gearing, M., Trojanowski, J. Q., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.009 · Cited by 195 · see citing works

Neuronal vulnerability in Parkinson’s disease

Hirsch, É. C., Faucheux, B. A., Damier, P., Prigent, A., & Agid, Y. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6842-4_9 · Cited by 192 · see citing works

Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators

Weinreb, O., Mandel, S. A., Youdim, M. B. H., & Amit, T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.017 · Cited by 190 · see citing works

Selective Translational Control of the Alzheimer Amyloid Precursor Protein Transcript by Iron Regulatory Protein-1

Cho, H.-H., Cahill, C. M., Vanderburg, C. R., Scherzer, C. R., Wang, B., Huang, X., & Rogers, J. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149161 · Cited by 188 · see citing works

Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures

Bronstein, D. M., Pérez‐Otaño, I., Sun, V., Sawin, S. B. M., Chan, J., Wu, G.-C., Hudson, P. M., Kong, L., Hong, J., & McMillian, M. (1995) · Brain Research · doi:10.1016/0006-8993(95)01189-7 · Cited by 186 · see citing works

Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases.<i>In vivo</i>selective brain monoamine oxidase inhibition and prevention of MPTP‐induced striatal dopamine depletion

Gal, S., Zheng, H., Fridkin, M., & Youdim, M. B. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03341.x · Cited by 185 · see citing works

Iron loading is a prominent feature of activated microglia in Alzheimer’s disease patients

Kenkhuis, B., Somarakis, A., de Haan, L., Dzyubachyk, O., IJsselsteijn, M. E., de Miranda, N. F. C. C., Lelieveldt, B. P. F., Dijkstra, J., van Roon-Mom, W. M. C., Höllt, T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01126-5 · Cited by 184 · see citing works

MR evaluation of age-related increase of brain iron in young adult and older normal males

Bartzokis, G., Beckson, M., Hance, D. B., Marx, P., Foster, J., & Marder, S. R. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(96)00234-2 · Cited by 181 · see citing works

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery

Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179 · see citing works

The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer’s disease

Raha, A. A., Vaishnav, R., Friedland, R. P., Bomford, A. B., & Raha‐Chowdhury, R. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-55 · Cited by 179 · see citing works

Ultrasmall NaGdF4 Nanodots for Efficient MR Angiography and Atherosclerotic Plaque Imaging

Xing, H., Zhang, S., Bu, W., Zheng, X., Wang, L., Xiao, Q., Ni, D., Zhang, J., Zhou, L., Peng, W., et al. (2014) · Advanced Materials · doi:10.1002/adma.201305222 · Cited by 178 · see citing works

Brain iron deposition and the free radical-mitochondrial theory of ageing

Schipper, H. M. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.02.001 · Cited by 177 · see citing works

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores

Bartzokis, G., Aravagiri, M., Oldendorf, W. H., Mintz, J., & Marder, S. R. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910290406 · Cited by 172 · see citing works

Role of mitochondria in the etiology and pathogenesis of Parkinson's disease

Mizuno, Y., Ikebe, S., Hattori, N., Nakagawa-Hattori, Y., Mochizuki, H., Tanaka, M., & Ozawa, T. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00038-6 · Cited by 170 · see citing works

Iron and α-Synuclein in the Substantia Nigra of MPTP-Treated Mice: Effect of Neuroprotective Drugs R-Apomorphine and Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate

Mandel, S. A., Maor, G., & Youdim, M. B. H. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:3:401 · Cited by 171 · see citing works

Parkinson’s disease is associated with DNA methylation levels in human blood and saliva

Chuang, Y., Paul, K. C., Bronstein, J. M., Bordelon, Y. M., Horvath, S., & Ritz, B. R. (2017) · Genome Medicine · doi:10.1186/s13073-017-0466-5 · Cited by 168 · see citing works

T 2 relaxation time in patients with Parkinson's disease

Antonini, A., Leenders, K. L., Meier, D., Oertel, W. H., Boesiger, P., & Anliker, M. (1993) · Neurology · doi:10.1212/wnl.43.4.697 · Cited by 168 · see citing works

Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease

Molina, J. A., Jiménez-Jiménez, F. J., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González-Muñoz, M. J., de Bustos, F., Porta, J., Ortí-Pareja, M., Zurdo, M., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050071 · Cited by 167 · see citing works

Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping

Guan, X., Xuan, M., Gu, Q., Huang, P., Liu, C., Wang, N., Xu, X., Luo, W. F., & Zhang, M. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3489 · Cited by 162 · see citing works

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes

Wang, Y., Wu, S., Li, Q., Sun, H., & Wang, H. (2023) · Advanced Science · doi:10.1002/advs.202300325 · Cited by 161 · see citing works

Altered hippocampal transcript profile accompanies an age-related spatial memory deficit in mice

Verbitsky, M., Yonan, A. L., Malleret, G., Kandel, E. R., Gilliam, T. C., & Pavlidis, P. (2004) · Learning &amp; Memory · doi:10.1101/lm.68204 · Cited by 158 · see citing works

Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin-Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC-70

Mandel, S. A., Grünblatt, E., Riederer, P. F., Amariglio, N., Hirsch, J. J., Rechavi, G., & Youdim, M. B. H. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1344.031 · Cited by 158 · see citing works

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

Oestreicher, E., Sengstock, G. J., Riederer, P., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90833-8 · Cited by 156 · see citing works

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

Morris, G., Berk, M., Carvalho, A. F., Maes, M. H. J., Walker, A. J., & Puri, B. K. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.036 · Cited by 154 · see citing works

Metals and Alzheimer’s Disease: How Far Have We Come in the Clinic?

Adlard, P. A., & Bush, A. I. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170662 · Cited by 155 · see citing works

Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders

Mena, N. P., Urrutia, P. J., Lourido, F., Carrasco, C. M., & Núñez, M. T. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.02.001 · Cited by 154 · see citing works

Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration

Andersen, H. H., Johnsen, K. B., & Moos, T. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1509-8 · Cited by 151 · see citing works

The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings.

Oikawa, H., Sasaki, M., Tamakawa, Y., Ehara, S., & Tohyama, K. (2002) · PubMed Central · Cited by 149 · see citing works

Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease

Cristóvão, J. S., Santos, R., & Gomes, C. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9812178 · Cited by 146 · see citing works

Hereditary Ferritinopathy: A Novel Mutation, Its Cellular Pathology, and Pathogenetic Insights

Mancuso, M., Davidzon, G., Kurlan, R., Tawil, R., Bonilla, E., Mauro, S. D., & Powers, J. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.4.280 · Cited by 146 · see citing works

The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin

Peters, D. G., Connor, J. R., & Meadowcroft, M. D. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.007 · Cited by 145 · see citing works

Point mutations of mitochondrial genome in Parkinson's disease

Ikebe, S.-I., Tanaka, M., & Ozawa, T. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00209-w · Cited by 144 · see citing works

Studies on lipid peroxidation in the rat brain

Cini, M., Fariello, R. G., Bianchetti, A., & Moretti, A. (1994) · Neurochemical Research · doi:10.1007/bf00971576 · Cited by 141 · see citing works

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

Sofic, E., Paulus, W., Jellinger, K. A., Riederer, P. F., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02017.x · Cited by 523 · see citing works

Distribution of Iron in the Basal Ganglia and Neocortex in Postmortem Tissue in Parkinson's Disease and Alzheimer's Disease

Griffiths, P. D., & Crossman, A. R. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107298 · Cited by 113 · see citing works

The Possible Role of Iron in Neurodegeneration

Gałązka-Friedman, J., & Friedman, A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_23

Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy

Kuiper, M. A., Mulder, C., van Kamp, G. J., Scheltens, P., & Wolters, E. C. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260965 · Cited by 52 · see citing works

Morphochemical study of alpha-synuclein, iron and iron-containing proteins in the substantia nigra of the brain in Parkinson’s disease

Николаевич, С. В., Худоерков, Р. М., Воронков, Д. Н., & Sobolev, V. B. (2022) · Russian Journal of Archive of Pathology · doi:10.17116/patol20228402113